Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadifloxacin + Tretinoin vs Clindamycin + Tretinoin in Mild-to-Moderate Acne
NCT07915648Phase 4Recruiting
- Sponsor
- Nishtar Medical University
- Start
- Sep 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of nadifloxacin in acne vulgaris (2 arms), sponsored by Nishtar Medical University. Primary endpoint: Reduction in number of inflammatory acne lesions at 12 weeks. Started Sep 2026; status: recruiting.
02
Drugs
nadifloxacin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07915648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07915648.